col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Association for Cancer Research: Cancer Discovery
  original article Date Title Authors   All Authors
1 [GO] 2021―Dec―22 Pandemic Provides Rapid Test of Telehealth
2 [GO] 2021―Dec―10 Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer Arielle Elkrief, Julie T Wu, Chinmay Jani, Kyle T Enriquez, Michael Glover, Mansi R Shah, et al. (+13)
3 [GO] 2021―Dec―09 Navigating Cancer Care in the COVID-19 Era
4 [GO] 2021―Nov―09 Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies Christina Y. Lee, Monika K Shah, David Hoyos, Alexander Solovyov, Melanie Douglas, Ying Taur, et al. (+5)
5 [GO] 2021―Oct―06 COVID-19 Use Causes Tocilizumab Shortage
6 [GO] 2021―Sep―01 Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19? Bérengère Salomé, Amir Horowitz
7 [GO] 2021―Jul―21 Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective Keith T. Flaherty, James H. Doroshow, Susan Galbraith, Antoni Ribas, Paul G. Kluetz, Richard Pazdur, Marc R. Theoret
8 [GO] 2021―Jul―16 Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine
9 [GO] 2021―Jul―07 COVID-19 Vaccines Complicate Breast Screening
10 [GO] 2021―Jun―04 COVID-19 Reshapes Cancer Clinical Research
11 [GO] 2021―May―19 Preexisting and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S Heitmann, Marissa L Dubbelaar, et al. (+16)
12 [GO] 2021―May―14 Blood Cancers Diminish Response to COVID-19 Vaccine
13 [GO] 2021―Apr―12 Repurposing of anticancer drugs expands possibilities for antiviral and anti-inflammatory discovery in COVID-19 Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, Antoni Ribas, Jean-Charles Soria
14 [GO] 2021―Apr―02 Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic Chris Labaki, Solange Peters, Toni K. Choueiri
15 [GO] 2021―Feb―26 COVID-19 Prolonged in Patients with Cancer
16 [GO] 2021―Feb―02 Correction: Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers
17 [GO] 2020―Dec―30 Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection
18 [GO] 2020―Dec―22 Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited Antoni Ribas, Rajarshi Sengupta, Trevan Locke, Sayyed Kaleem Zaidi, Katie M Campbell, John M. Carethers, et al. (+4)
19 [GO] 2020―Dec―22 As Pandemic Continues, Screening Concerns Grow
20 [GO] 2020―Dec―11 Survival Factors ID'd for Patients with Blood Cancer + COVID-19
21 [GO] 2020―Sep―18 Repurposing Cancer Drugs for COVID-19
22 [GO] 2020―Sep―16 Q&A: Solange Peters on COVID-19, Cancer Intersection; Immunotherapy Biomarkers
23 [GO] 2020―Sep―01 COVID-19 Challenges Status Quo for Cancer Care
24 [GO] 2020―Aug―19 ICI Impact on COVID-19 Severity Modest at Best
25 [GO] 2020―Jul―31 Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. David J Pinato, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher CT Sng, Ramon Salazar, et al. (+58)
26 [GO] 2020―Jul―22 Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M. Kuderer, Chih-Yuan Hsu, et al. (+39)
27 [GO] 2020―Jul―15 Cancer Research: The lessons to learn from COVID-19 Chris Bailey, James R M Black, Charles Swanton
28 [GO] 2020―Jun―08 COVID-19 Delays Cancer Screenings
29 [GO] 2020―May―29 Registries Offer Insights on COVID-19-Cancer Connection
30 [GO] 2020―May―22 The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 Beril Tutuncuoglu, Merve Cakir, Jyoti Batra, Mehdi Bouhaddou, Manon Eckhardt, David E Gordon, Nevan J Krogan
31 [GO] 2020―May―13 The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research Tobias Janowitz, David A. Tuveson
32 [GO] 2020―May―12 Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers Jia Luo, Hira Rizvi, Jacklynn V Egger, Isabel R Preeshagul, Jedd D. Wolchok, Matthew D. Hellmann
33 [GO] 2020―May―05 Cytokine Storm Drugs Move from CAR T to COVID-19
34 [GO] 2020―May―01 Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System Vikas Mehta, Sanjay Goel, Rafi Kabarriti, Daniel Cole, Mendel Goldfinger, Ana Acuna-Villaorduna, et al. (+13)
35 [GO] 2020―Apr―28 Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak Mengyuan Dai, Dianbo Liu, Miao Liu, Fuxiang Zhou, Guiling Li, Zhen Chen, et al. (+32)
36 [GO] 2020―Apr―24 COVID-19 Hits Cancer Research Funding
37 [GO] 2020―Apr―20 COVID-19 More Frequent, Severe in Cancer Patients
38 [GO] 2020―Apr―17 Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients Sangya Agarwal, Carl H. June
39 [GO] 2020―Apr―15 AACR Calls on Congress to Take Immediate Action Against COVID-19 and Protect Patients with Cancer During the Pandemic
40 [GO] 2020―Apr―10 Cancer Care Goes Virtual in Response to COVID-19
41 [GO] 2020―Apr―10 TMPRSS2 and COVID-19: Serendipity or opportunity for intervention? Konrad H. Stopsack, Lorelei A. Mucci, Emmanuel S. Antonarakis, Peter S. Nelson, Philip W. Kantoff
42 [GO] 2020―Apr―01 Clinical Research Slows as COVID-19 Surges
43 [GO] 2020―Mar―31 Cancer Labs Pivot to Battle COVID-19
44 [GO] 2020―Mar―24 COVID-19 Challenges Basic Researchers


[de][en]

Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.022 sec